Q2 2022 Holdings
Filed 2022-08-15 | 33 holdings | $2.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moderna Inc(MRNA) | COM | 60770K107 | $1.8M | 12,886,743 | 69.3% |
| Sana Biotechnology Inc(SANA) | COM | 799566104 | $220.2K | 34,239,018 | 8.3% |
| Foghorn Therapeutics Inc(FHTX) | COM | 344174107 | $172.4K | 12,674,120 | 6.5% |
| Evelo Biosciences Inc | COM | 299734103 | $106.4K | 50,427,328 | 4.0% |
| Omega Therapeutics Inc | COM | 68217N105 | $98.4K | 25,902,269 | 3.7% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $77.1K | 2,619,968 | 2.9% |
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $49.3K | 14,378,802 | 1.9% |
| Axcella Health Inc | COM | 05454B105 | $38.3K | 18,867,785 | 1.4% |
| Rubius Therapeutics Inc | COM | 78116T103 | $32.7K | 38,506,526 | 1.2% |
| Sigilon Therapeutics Inc | COM | 82657L107 | $8.6K | 10,370,369 | 0.3% |
| Codiak Biosciences Inc(32W) | COM | 192010106 | $7.5K | 2,607,303 | 0.3% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $2.8K | 2,938,494 | 0.1% |